Keryx Biopharma Shares Rally On Orphan-Drug Designation - Wall Street Journal
Keryx Biopharma Shares Rally On Orphan-Drug DesignationWall Street JournalKeryx Biopharmaceuticals Inc. (KERX) said the US Food and Drug Administration has given orphan-drug designation to perifosine, a treatment for cancer ...and more��
Blog Content
No comments:
Post a Comment